Screening for breast cancer is receiving increased emphasis with the development of modern technology. Health care providers must inform the public that screening for breast cancer may increase survival. Legislation must be enacted to ensure that a screening examination is affordable and can be readily...
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-1792.PubMedGoogle ScholarCrossref 5. Smith RA, Saslow D, Sawyer KA, et al; American Cancer Society High-Risk Work Group; American Cancer Society Screening Older Women Work Group; ...
Breast cancer is one of the leading cause of mortality and morbidity in Canada. Screening is the most promising approach in identification and treatment of the disease at early stage of its development. Research shows higher rate of breast cancer mortali
Article CAS PubMed PubMed Central Google Scholar Lee, C. H. et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breas...
Breast Cancer Res. 2022;24(1):37. doi:10.1186/s13058-022-01533-zPubMedGoogle ScholarCrossref 23. Niraula S, Biswanger N, Hu P, Lambert P, Decker K. Incidence, characteristics, and outcomes of interval breast cancers compared with screening-detected breast cancers. ...
PubMed ID:: 2406115 Keywords: Breast Neoplasms,diagnosis,prevention & control,therapy,Combined Modality Therapy,Female,Humans,Mass Screening,Neoplasm Metastasis Data availability: Keywords: Breast Neoplasms, diagnosis, prevention & control, therapy, Combined Modality Therapy, Female, Humans, Mass Screenin...
The sensitivity of a mammography program is normally evaluated by comparing the interval cancer rate to the expected breast cancer incidence without screening, i.e. the proportional interval cancer rate (PICR). The expected breast cancer incidence in absence of screening is, however, difficult to ...
While IBCs do not represent a unique molecular class of invasive breast cancer they exhibit a more aggressive phenotype, which is likely to be a consequence of the timing of tumour initiation. This information is relevant both with respect to treatment as well as informing the screening interval ...
Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-884. doi:10.1001/jamaoncol.2021.0884 ArticlePubMedGoogle ScholarCrossref 3. Guan A, Lichtensztajn D, Oh D, et al; San Francisco Cancer Initiative Breast...
Article PubMed CAS Google Scholar U.K. Trial of Early Detection of Breast Cancer Group: First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet ii: 411–416, 1988 Google Scholar O'Malley MS, Fletcher SW: Screening for breast cancer with breast se...